The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Desai Veeral since 2021.
This trader's CIK number is 1855973.
At the time of last reporting, Desai Veeral was the Chief Strategy & Dev. Officer of Agilon Health, Inc.. (stock ticker symbol AGL).
Also see all insider trading activities at Agilon Health, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | AGL | 11,956 | $0 | 0 | $0 | 0 | $0 |
| 2023 | AGL | 0 | $0 | 190,000 | $5,276,925 | 190,000 | $570,000 |
| 2022 | AGL | 0 | $0 | 1,021,558 | $23,582,266 | 1,021,558 | $1,021,558 |
| 2021 | AGL | 0 | $0 | 121,001 | $3,506,608 | 121,001 | $121,001 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-03-14 | AGL | Buy | 11,956 | .00 | 0 |
| 2023-05-09 | AGL | Sale | 4,500 | 26.15 | 117,666 |
| 2023-05-09 | AGL | Option Ex | 4,500 | 3.00 | 13,500 |
| 2023-04-19 | AGL | Option Ex | 5,000 | 3.00 | 15,000 |
| 2023-04-20 | AGL | Option Ex | 500 | 3.00 | 1,500 |
| 2023-04-19 | AGL | Sale | 5,000 | 27.33 | 136,635 |
| 2023-04-20 | AGL | Sale | 500 | 26.15 | 13,074 |
| 2023-03-24 | AGL | Sale | 97,290 | 28.70 | 2,792,417 |
| 2023-03-23 | AGL | Sale | 22,710 | 28.71 | 651,913 |
| 2023-03-24 | AGL | Option Ex | 97,290 | 3.00 | 291,870 |
| 2023-03-23 | AGL | Option Ex | 22,710 | 3.00 | 68,130 |
| 2023-03-16 | AGL | Sale | 60,000 | 26.09 | 1,565,220 |
| 2023-03-16 | AGL | Option Ex | 60,000 | 3.00 | 180,000 |
| 2022-07-21 | AGL | Option Ex | 79,768 | 1.00 | 79,768 |
| 2022-07-21 | AGL | Sale | 79,768 | 27.50 | 2,193,620 |
| 2022-07-07 | AGL | Option Ex | 319,071 | 1.00 | 319,071 |
| 2022-07-07 | AGL | Sale | 319,071 | 25.00 | 7,976,775 |
| 2022-06-24 | AGL | Option Ex | 106,357 | 1.00 | 106,357 |
| 2022-06-24 | AGL | Sale | 106,357 | 22.50 | 2,393,032 |
| 2022-04-21 | AGL | Option Ex | 79,568 | 1.00 | 79,568 |
| 2022-04-22 | AGL | Option Ex | 26,789 | 1.00 | 26,789 |
| 2022-04-21 | AGL | Sale | 79,568 | 20.89 | 1,661,777 |
| 2022-04-22 | AGL | Sale | 26,789 | 20.00 | 535,780 |
| 2022-04-20 | AGL | Sale | 106,357 | 22.34 | 2,376,015 |
| 2022-04-19 | AGL | Sale | 106,357 | 22.74 | 2,418,558 |
| 2022-04-20 | AGL | Option Ex | 106,357 | 1.00 | 106,357 |
| 2022-04-19 | AGL | Option Ex | 106,357 | 1.00 | 106,357 |
| 2022-03-16 | AGL | Option Ex | 197,291 | 1.00 | 197,291 |
| 2022-03-16 | AGL | Sale | 197,291 | 20.41 | 4,026,709 |
| 2021-09-14 | AGL | Option Ex | 121,001 | 1.00 | 121,001 |
| 2021-09-14 | AGL | Sale | 121,001 | 28.98 | 3,506,608 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Desai Veeral (Chief Strategy & Dev. Officer of Agilon Health, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.